D. Peace

Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.

J. Bluestone, R. Zivin, J. Auger, 1999, Cancer research.

Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.

J. Bluestone, R. Zivin, J. Auger, 2002, The Journal of rheumatology.

Experiences in a small respiratory unit of a general hospital

D. Peace, 1961 .

HIV-1 Infection and Transmission Networks of Younger People in Chicago, Illinois, 2005-2011

N. Benbow, A. Oster, J. Schneider, 2017, Public health reports.

Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.

J. Bluestone, E. Woodle, D. Xu, 1999, Transplantation.